4DX Stock Overview
Operates as a medical technology company in the United States and Australia. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
4DMedical Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.28 |
| 52 Week High | AU$0.71 |
| 52 Week Low | AU$0.23 |
| Beta | 1.4 |
| 1 Month Change | -1.75% |
| 3 Month Change | -45.10% |
| 1 Year Change | -54.47% |
| 3 Year Change | -56.92% |
| 5 Year Change | n/a |
| Change since IPO | -81.70% |
Recent News & Updates
Recent updates
Shareholder Returns
| 4DX | AU Healthcare Services | AU Market | |
|---|---|---|---|
| 7D | -3.4% | 8.4% | 1.3% |
| 1Y | -54.5% | 114.5% | 5.0% |
Return vs Industry: 4DX underperformed the Australian Healthcare Services industry which returned 107.8% over the past year.
Return vs Market: 4DX underperformed the Australian Market which returned 3.5% over the past year.
Price Volatility
| 4DX volatility | |
|---|---|
| 4DX Average Weekly Movement | 10.9% |
| Healthcare Services Industry Average Movement | 12.5% |
| Market Average Movement | 9.5% |
| 10% most volatile stocks in AU Market | 16.8% |
| 10% least volatile stocks in AU Market | 4.1% |
Stable Share Price: 4DX has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: 4DX's weekly volatility (11%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 145 | Andreas Fouras | 4dmedical.com |
4DMedical Limited operates as a medical technology company in the United States and Australia. It engages in the medical research technology and development of a non-invasive respiratory imaging solution using four-dimensional imaging. The company also offers X-ray velocimetry lung ventilation analysis software (XV LVAS), a lung airflow imaging software, that provides lung health detail from X-Ray scans; computed tomography lung ventilation analysis software (CT LVAS), an image processing software which operates on CT scans to provide functional lung health detail; XV Scanner, a lung function scanner; and Permetium, a multi-function imaging system for pulmonary investigations.
4DMedical Limited Fundamentals Summary
| 4DX fundamental statistics | |
|---|---|
| Market cap | AU$126.15m |
| Earnings (TTM) | -AU$39.54m |
| Revenue (TTM) | AU$5.86m |
21.5x
P/S Ratio-3.2x
P/E RatioIs 4DX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4DX income statement (TTM) | |
|---|---|
| Revenue | AU$5.86m |
| Cost of Revenue | AU$374.59k |
| Gross Profit | AU$5.48m |
| Other Expenses | AU$45.02m |
| Earnings | -AU$39.54m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.088 |
| Gross Margin | 93.60% |
| Net Profit Margin | -675.09% |
| Debt/Equity Ratio | 0% |
How did 4DX perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/16 06:15 |
| End of Day Share Price | 2025/05/16 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
4DMedical Limited is covered by 2 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| John Hester | Bell Potter |
| Thomas Godfrey | Ord Minnett Limited |